{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:39:54Z","timestamp":1781051994316,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2011\/01291-3"],"award-info":[{"award-number":["2011\/01291-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["305182\/2014-5"],"award-info":[{"award-number":["305182\/2014-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.mce.2019.110451","type":"journal-article","created":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T10:16:13Z","timestamp":1558174573000},"page":"110451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Ubiquitin proteasome system (UPS) activation in the cardiac hypertrophy of hyperthyroidism"],"prefix":"10.1016","volume":"493","author":[{"given":"Caroline Antunes","family":"Lino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilene","family":"Demasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5514-7921","authenticated-orcid":false,"given":"Maria Luiza","family":"Barreto-Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2019.110451_bib1","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.2741\/4027","article-title":"Immune and non-immune functions of the immunoproteasome","author":"Angeles","year":"2012","journal-title":"Front. Biosci."},{"key":"10.1016\/j.mce.2019.110451_bib2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1083\/jcb.200402033","article-title":"Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy","volume":"167","author":"Arya","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mce.2019.110451_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1590\/S0100-879X2000000600007","article-title":"Stimulatory effect of dexamethasone on angiotensin-converting enzyme in neonatal rat cardiac myocytes","volume":"33","author":"Barreto-Chaves","year":"2000","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.mce.2019.110451_bib4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cvr\/cvn083","article-title":"Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy","volume":"79","author":"Birks","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2019.110451_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.mce.2019.110451_bib6","first-page":"1","article-title":"Role of ubiquitin-proteasome system (UPS) in left ventricular hypertrophy (LVH)","volume":"4","author":"Cacciapuoti","year":"2014","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.mce.2019.110451_bib7","first-page":"464195","article-title":"Increased clearance of reactive aldehydes and damaged proteins in hypertension-induced compensated cardiac hypertrophy: impact of exercise training","author":"Campos","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.mce.2019.110451_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00395-010-0089-0","article-title":"Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation","volume":"105","author":"Carneiro-Ramos","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.mce.2019.110451_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1006\/jmbi.2001.4448","article-title":"Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain","volume":"306","author":"Centner","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.mce.2019.110451_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.redox.2018.10.021","article-title":"Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload","volume":"20","author":"Chen","year":"2018","journal-title":"Redox Biol"},{"key":"10.1016\/j.mce.2019.110451_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2091-8-S1-S3","article-title":"Role of proteasomes in disease","volume":"8","author":"Dahlmann","year":"2007","journal-title":"BMC Biochem."},{"key":"10.1016\/j.mce.2019.110451_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.abb.2015.12.012","article-title":"Mammalian proteasome subtypes: their diversity in structure and function","volume":"591","author":"Dahlmann","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mce.2019.110451_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/cvr\/cvp255","article-title":"Stressing the ubiquitin-proteasome system","volume":"85","author":"Dantuma","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2019.110451_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0300-9084(01)01250-0","article-title":"Degradation of oxidized proteins by the 20S proteasome","volume":"83","author":"Davies","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.mce.2019.110451_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/105072502760143827","article-title":"Nongenomic actions of thyroid hormone on the heart","volume":"12","author":"Davis","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.mce.2019.110451_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrendo.2015.205","article-title":"Nongenomic actions of thyroid hormone","volume":"12","author":"Davis","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2019.110451_bib17","doi-asserted-by":"crossref","first-page":"H1283","DOI":"10.1152\/ajpheart.00249.2012","article-title":"The ubiquitin proteasome system in human cardiomyopathies and heart failure","volume":"304","author":"Day","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2019.110451_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10741-008-9125-7","article-title":"Cardiac hypertrophy and thyroid hormone signaling","volume":"15","author":"Dillmann","year":"2010","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.mce.2019.110451_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00395-009-0043-1","article-title":"Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt\/GSK-3beta\/mTOR signaling pathway","volume":"104","author":"Diniz","year":"2009","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.mce.2019.110451_bib20","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.110.222364","article-title":"Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy","volume":"107","author":"Drews","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2019.110451_bib21","first-page":"854265","article-title":"Role of oxidative stress in thyroid hormone-induced cardiomyocyte hypertrophy and associated cardiac dysfunction: an undisclosed story","author":"Elnakish","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.mce.2019.110451_bib22","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","article-title":"Protein degradation and protection against misfolded or damaged proteins","volume":"426","author":"Goldberg","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.mce.2019.110451_bib23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cvr\/cvp226","article-title":"Proteasome inhibitors and cardiac cell growth","volume":"85","author":"Hedhli","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2019.110451_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cardiores.2005.06.025","article-title":"Protein turnover in cardiac cell growth and survival","volume":"68","author":"Hedhli","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2019.110451_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cvr\/cvm054","article-title":"Proteasome activation during cardiac hypertrophy by the chaperone H11 Kinase\/Hsp22","volume":"77","author":"Hedhli","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2019.110451_bib26","doi-asserted-by":"crossref","first-page":"R1473","DOI":"10.1152\/ajpregu.00269.2003","article-title":"Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling","volume":"285","author":"Hu","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.mce.2019.110451_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00428-004-1175-1","article-title":"Myocardial ultrastructure in cardiac hypertrophy induced by thyroid hormone--an acute study in rats","volume":"446","author":"Hu","year":"2005","journal-title":"Virchows Arch."},{"key":"10.1016\/j.mce.2019.110451_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048601","article-title":"Pregnancy is associated with decreased cardiac proteasome activity and oxidative stress in mice","volume":"7","author":"Iorga","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2019.110451_bib29","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/er.2003-0033","article-title":"Thyroid hormone action in the heart","volume":"26","author":"Kahaly","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2019.110451_bib30","doi-asserted-by":"crossref","first-page":"18135","DOI":"10.1073\/pnas.0404341102","article-title":"Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I","volume":"101","author":"Kedar","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2019.110451_bib31","doi-asserted-by":"crossref","first-page":"20666","DOI":"10.1074\/jbc.M512671200","article-title":"Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways","volume":"281","author":"Kenessey","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2019.110451_bib32","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/pmic.200900283","article-title":"Co- and post-translational modifications of the 26S proteasome in yeast","volume":"10","author":"Kikuchi","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.mce.2019.110451_bib33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/hh1901.096706","article-title":"Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy","volume":"89","author":"Kinugawa","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2019.110451_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9343(90)90531-H","article-title":"Thyroid hormone and the cardiovascular system","volume":"88","author":"Klein","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.mce.2019.110451_bib35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2019.110451_bib36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5483\/BMBRep.2016.49.5.187","article-title":"Proteasome inhibitors attenuated cholesterol-induced cardiac hypertrophy in H9c2 cells","volume":"49","author":"Lee","year":"2016","journal-title":"BMB Rep"},{"key":"10.1016\/j.mce.2019.110451_bib37","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1172\/JCI200422220","article-title":"Atrogin-1\/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex","volume":"114","author":"Li","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mce.2019.110451_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yjmcc.2014.12.007","article-title":"Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP","volume":"79","author":"Li","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.mce.2019.110451_bib39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCHEARTFAILURE.113.000713","article-title":"Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A","volume":"7","author":"Maejima","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.mce.2019.110451_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/cvr\/cvp348","article-title":"Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms","volume":"85","author":"Mearini","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2019.110451_bib41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.bbadis.2008.06.009","article-title":"The ubiquitin-proteasome system in cardiac dysfunction","volume":"1782","author":"Mearini","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mce.2019.110451_bib42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.107.097816","article-title":"Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system","volume":"51","author":"Meiners","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2019.110451_bib43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.vph.2009.11.008","article-title":"Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy","volume":"52","author":"Ojamaa","year":"2010","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.mce.2019.110451_bib44","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00062.2006","article-title":"The ubiquitin-proteasome system in cardiac physiology and pathology","volume":"291","author":"Powell","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2019.110451_bib45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/B978-0-12-397863-9.00009-2","article-title":"The ubiquitin-proteasome system and cardiovascular disease","volume":"109","author":"Powell","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.mce.2019.110451_bib46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.yjmcc.2007.12.009","article-title":"Upregulation of myocardial 11S-activated proteasome in experimental hyperglycemia","volume":"44","author":"Powell","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.mce.2019.110451_bib47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mam.2016.05.001","article-title":"Degradation of oxidized proteins by the proteasome: distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways","volume":"50","author":"Raynes","year":"2016","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.mce.2019.110451_bib48","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41580-018-0040-z","article-title":"Regulation of proteasome assembly and activity in health and disease","volume":"11","author":"Rousseau","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mce.2019.110451_bib49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.mce.2019.110451_bib50","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35008096","article-title":"Rapid degradation of a large fraction of newly synthesized proteins by proteasomes","volume":"404","author":"Schubert","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.mce.2019.110451_bib51","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00189.2012","article-title":"Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics","volume":"303","author":"Scruggs","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2019.110451_bib52","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1042\/CS20171606","article-title":"Angiotensin-(1-7) reduces cardiac effects of thyroid hormone by GSK3\u0392\/NFATc3 signaling pathway","volume":"132","author":"Senger","year":"2018","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.mce.2019.110451_bib53","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00109-017-1511-y","article-title":"S100A8\/MYD88\/NF-\u049bB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone","volume":"95","author":"Takano","year":"2017","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.mce.2019.110451_bib54","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00424-017-2088-6","article-title":"AT1 receptor blockage impairs NF-\u03baB activation mediated by thyroid hormone in cardiomyocytes","volume":"470","author":"Takano","year":"2018","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.mce.2019.110451_bib55","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/cvr\/cvq217","article-title":"Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts","volume":"88","author":"Tang","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2019.110451_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10557-013-6473-x","article-title":"Angiotensin II type 2 receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion","volume":"27","author":"Tavares","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.mce.2019.110451_bib57","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bbrc.2005.12.120","article-title":"Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice","volume":"340","author":"Tsukamoto","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2019.110451_bib58","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1121925","article-title":"Protein synthesis upon acute nutrient restriction relies on proteasome function","volume":"310","author":"Vabulas","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.mce.2019.110451_bib59","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00018-005-5457-9","article-title":"Thyroid hormone-induced oxidative stress","volume":"63","author":"Venditti","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.mce.2019.110451_bib60","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/JME-15-0283","article-title":"MuRF1 mono-ubiquitinates TR\u03b1 to inhibit T3-induced cardiac hypertrophy in vivo","volume":"56","author":"Wadosky","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.mce.2019.110451_bib61","doi-asserted-by":"crossref","first-page":"E723","DOI":"10.1152\/ajpendo.00326.2013","article-title":"Muscle RING finger-1 attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling","volume":"306","author":"Wadosky","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2019.110451_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yjmcc.2008.03.025","article-title":"Protein quality control and degradation in cardiomyocytes","volume":"45","author":"Wang","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.mce.2019.110451_bib63","doi-asserted-by":"crossref","first-page":"ra88","DOI":"10.1126\/scisignal.2001232","article-title":"Regulation of the 26S proteasome complex during oxidative stress","volume":"3","author":"Wang","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.mce.2019.110451_bib64","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/pmic.200390029","article-title":"Hyperubiquitination of proteins in dilated cardiomyopathy","volume":"3","author":"Weekes","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.mce.2019.110451_bib65","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1056\/NEJMra1106180","article-title":"Proteotoxicity and cardiac dysfunction","volume":"368","author":"Willis","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2019.110451_bib66","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.yjmcc.2015.07.027","article-title":"The mammalian target of rapamycin modulates the immunoproteasome system in the heart","volume":"86","author":"Zhang","year":"2015","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720719301534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720719301534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T09:43:52Z","timestamp":1569145432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720719301534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":66,"alternative-id":["S0303720719301534"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2019.110451","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ubiquitin proteasome system (UPS) activation in the cardiac hypertrophy of hyperthyroidism","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2019.110451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110451"}}